Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New cannabinoid CB1 and CB2 receptor ligands identified at Canopy Growth Corp.

Feb. 4, 2021

DexTech expands preclinical program to evaluate OsteoDex in multiple myeloma

Feb. 3, 2021

Curis initiates phase II LUCAS study of CA-4948 as treatment for anemia in MDS

Feb. 3, 2021

Phase I data presented for AXL inhibitor DS-1205c plus osimertinib in EGFR-mutated NSCLC

Feb. 3, 2021

Annamycin shows significant therapeutic benefit in metastatic osteosarcoma animal model

Feb. 3, 2021

WCLC 2021: KRAS drugs may do best in tough subtype

Feb. 2, 2021

Updated results presented from TRIDENT-1 study of repotrectinib

Feb. 2, 2021

Mobocertinib shows clinical benefit in patients with exon 20-mutated NSCLC

Feb. 2, 2021

Sun Pharma Advanced Research describes new camptothecin derivative prodrugs

Feb. 2, 2021

Allinky Biopharma presents GTPase KRas inhibitors

Feb. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...